SHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer—PFS ratio from patients who crossed-over.-Reference-Cited by-同舟云学术

SHIVA: Randomized phase II trial comparing molecularly targeted therapy based on tumor molecular profiling versus conventional therapy in patients with refractory cancer—PFS ratio from patients who crossed-over.

Published:2016-05-20 Issue:15_suppl Volume:34 Page:2535-2535
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Le Tourneau Christophe¹,Kamal Maud¹,Mauborgne Cecile¹,Mulot Fabrice¹,Delord Jean-Pierre²,Goncalves Anthony³,Gavoille Celine⁴,Dubot Coraline⁵,Isambert Nicolas⁶,Campone Mario⁷,Tredan Olivier⁸,Ricci Francesco¹,Alt Marie⁹,Loirat Delphine¹,Sablin Marie-Paule¹,Paoletti Xavier¹⁰,Servois Vincent¹,Belin Lisa¹

Affiliation:

1. Institut Curie, Paris, France;

2. Institut Claudius Regaud, Toulouse, France;

3. Department of Medical Oncology, Institut Paoli-Calmettes, Marseille, France;

4. Institut de Cancérologie de Lorraine, Département d'Oncologie Médicale, Nancy, France;

5. Hôpital René Huguenin/Institut Curie, Saint-Cloud, France;

6. Centre Georges François Leclerc, Dijon, France;

7. Cancer Institute of the West (ICO), Centre René Gauducheau, Medical Oncology Department, Saint-Herblain, France;

8. Département d'Oncologie Médicale, Centre Léon Bérard, Lyon, France;

9. Medical Oncology, Institut Curie, Paris, France;

10. Institut Gustave Roussy, Villejuif, France;

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2016.34.15_suppl.2535

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What have we learned from SHIVA?;Nature Reviews Clinical Oncology;2016-10-11